{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:03Z","timestamp":1759047003262,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.imlet.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T10:43:56Z","timestamp":1557744236000},"page":"23-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lack of association between serum IL-9 levels and Beh\u00e7et\u2019s disease"],"prefix":"10.1016","volume":"211","author":[{"given":"Masoud","family":"Nouri-Vaskeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golamreza","family":"Jadideslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2019.05.007_bib0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7861\/clinmedicine.17-1-71","article-title":"Behcet\u2019s disease","volume":"17","author":"Nair","year":"2017","journal-title":"Clin. Med."},{"issue":"5","key":"10.1016\/j.imlet.2019.05.007_bib0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/08820139.2017.1306865","article-title":"Th17-Inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behcet\u2019s disease","volume":"46","author":"Deniz","year":"2017","journal-title":"Immunol. Invest."},{"issue":"Suppl 67","key":"10.1016\/j.imlet.2019.05.007_bib0015","first-page":"S71","article-title":"Th17 cells in Behcet\u2019s disease: a new immunoregulatory axis","volume":"29","author":"Hamzaoui","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.imlet.2019.05.007_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5582\/irdr.2015.01007","article-title":"Cardiac manifestations in Behcet\u2019s disease","volume":"4","author":"Demirelli","year":"2015","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.imlet.2019.05.007_bib0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/112067210801800520","article-title":"Serum haptoglobin levels in ocular Beh\u00e7et disease and acute phase proteins in the course of Beh\u00e7et disease","volume":"18","author":"Yal\u00e7inda\u011f","year":"2008","journal-title":"Eur. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.imlet.2019.05.007_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/jcm6050049","article-title":"Serum profiles of cytokines in Behcet\u2019s Disease","volume":"6","author":"Sadeghi","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.imlet.2019.05.007_bib0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imlet.2018.10.013","article-title":"Critical regulation of Th17 cell differentiation by serum amyloid-a signalling in Behcet\u2019s disease","volume":"201","author":"Lucherini","year":"2018","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.imlet.2019.05.007_bib0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humimm.2016.12.010","article-title":"Th9 cells and IL-9 in autoimmune disorders: pathogenesis and therapeutic potentials","volume":"78","author":"Deng","year":"2017","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2019.05.007_bib0045","first-page":"200","article-title":"Cytokine signatures in mucocutaneous and ocular Beh\u00e7et\u2019s disease","volume":"27","author":"Lopalco","year":"2017","journal-title":"Front. Immunol."},{"issue":"42","key":"10.1016\/j.imlet.2019.05.007_bib0050","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1097\/MD.0000000000001858","article-title":"Putative role of serum amyloid-a and proinflammatory cytokines as biomarkers for Behcet\u2019s disease","volume":"94","author":"Lopalco","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.imlet.2019.05.007_bib0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cei.12807","article-title":"Interleukin-9 and T helper type 9 cells in rheumatic diseases","volume":"185","author":"Ciccia","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2019.05.007_bib0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11481-009-9186-y","article-title":"IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity","volume":"5","author":"Li","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"12","key":"10.1016\/j.imlet.2019.05.007_bib0065","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/rheumatology\/kev252","article-title":"Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.imlet.2019.05.007_bib0070","doi-asserted-by":"crossref","first-page":"e51752","DOI":"10.1371\/journal.pone.0051752","article-title":"Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.imlet.2019.05.007_bib0075","doi-asserted-by":"crossref","first-page":"e33271","DOI":"10.1371\/journal.pone.0033271","article-title":"IL-9 induces VEGF secretion from human mast cells and IL-9\/IL-9 receptor genes are overexpressed in atopic dermatitis","volume":"7","author":"Sismanopoulos","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.imlet.2019.05.007_bib0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1525-1470.2012.01766.x","article-title":"Serum interleukin-9 levels are associated with clinical severity in children with atopic dermatitis","volume":"30","author":"Ciprandi","year":"2013","journal-title":"Pediatr. Dermatol."},{"issue":"1","key":"10.1016\/j.imlet.2019.05.007_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.12198","article-title":"Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis","volume":"175","author":"Ma","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2019.05.007_bib0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3892\/mmr.2013.1258","article-title":"Increased interleukin 9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus","volume":"7","author":"Ouyang","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.imlet.2019.05.007_bib0095","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3899\/jrheum.140954","article-title":"Intrarenal and urinary Th9 and Th22 cytokine gene expression in lupus nephritis","volume":"42","author":"Luk","year":"2015","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.imlet.2019.05.007_bib0100","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.110268","article-title":"Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis","volume":"38","author":"Yanaba","year":"2011","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2019.05.007_bib0105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s12026-015-8765-7","article-title":"Th9 and Th22 immune response in young patients with type 1 diabetes","volume":"64","author":"Ryba-Stanislawowska","year":"2015","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.imlet.2019.05.007_bib0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/CS20140608","article-title":"T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis","volume":"129","author":"Ruocco","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.imlet.2019.05.007_bib0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2119\/molmed.2014.00237","article-title":"Interleukin-9 is associated with elevated anti-double-Stranded DNA antibodies in Lupus-Prone Mice","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Med."},{"issue":"7","key":"10.1016\/j.imlet.2019.05.007_bib0120","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.4049\/jimmunol.1000986","article-title":"Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2019.05.007_bib0125","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"Jager","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2019.05.007_bib0130","doi-asserted-by":"crossref","first-page":"e48566","DOI":"10.1371\/journal.pone.0048566","article-title":"IFN-beta inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.imlet.2019.05.007_bib0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/imm.12322","article-title":"Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses","volume":"143","author":"Yao","year":"2014","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.imlet.2019.05.007_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"Revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.imlet.2019.05.007_bib0145","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/kev102","article-title":"Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.imlet.2019.05.007_bib0150","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s10067-016-3399-2","article-title":"IL-9-producing Th9 cells may participate in pathogenesis of Takayasu\u2019s arteritis","volume":"35","author":"Pan","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.imlet.2019.05.007_bib0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Behcet\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease (ITR-ICBD)","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.imlet.2019.05.007_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/607921","article-title":"Diagnosis\/classification criteria for Behcet\u2019s disease","volume":"2012","author":"Davatchi","year":"2012","journal-title":"Pathol. Res. Int."},{"issue":"3","key":"10.1016\/j.imlet.2019.05.007_bib0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Davatchi","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.imlet.2019.05.007_bib0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Behcet\u2019s disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2019.05.007_bib0175","first-page":"134","article-title":"Iran Behcet\u2019s disease dynamic activity measure. Abstracts of the XIIth European congress of rheumatology","volume":"32","author":"Davatchi","year":"2019","journal-title":"Hung. Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2019.05.007_bib0180","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/s10165-009-0191-z","article-title":"Comparison of existing disease activity indices in the follow-up of patients with Behcet\u2019s disease","volume":"19","author":"Shahram","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.imlet.2019.05.007_bib0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Behcet\u2019s Disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2019.05.007_bib0190","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2019.05.007_bib0195","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cytogfr.2013.09.001","article-title":"Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases","volume":"24","author":"Pan","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.imlet.2019.05.007_bib0200","first-page":"538","article-title":"Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease","volume":"23","author":"Peng","year":"2017","journal-title":"Mol. Vis."},{"issue":"11","key":"10.1016\/j.imlet.2019.05.007_bib0205","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1172\/JCI78182","article-title":"Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis","volume":"125","author":"Millet","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.imlet.2019.05.007_bib0210","first-page":"1922","article-title":"IL-9 over-expression and Th9 polarization characterize the inflamed gut, the synovial tissue and the peripheral blood of patients with psoriatic arthritis","volume":"68","author":"Ciccia","year":"2016","journal-title":"."},{"key":"10.1016\/j.imlet.2019.05.007_bib0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cyto.2015.12.020","article-title":"Raychaudhuri SP. IL-9, a local growth factor for synovial T cells in inflammatory arthritis","volume":"79","author":"Kundu-Raychaudhuri","year":"2016","journal-title":"Cytokine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819301725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819301725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:34:45Z","timestamp":1759044885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247819301725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":43,"alternative-id":["S0165247819301725"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2019.05.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of association between serum IL-9 levels and Beh\u00e7et\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}